← All patents

US20240318198A1

Gene therapy for angelman syndrome

University of Texas System

Abstract

The present disclosure provides methods and compositions for the treatment of Angelman Syndrome The methods and compositions of the present disclosure comprise isolated nucleic acid molecules, rAAV vectors and rAAV viral vectors comprising polynucleotide sequences encoding for short hairpin RNA ( …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Ryan Butler
Priority date
February 03, 2021
Filing date
February 02, 2022
Publication date
September 26, 2024
Language
en
Metadata fetched
August 29, 2026 00:32